Dr Anna Brooks
Dr Anna Brooks holds a PhD in Immunology and is a Senior Research Fellow with the Maurice Wilkins Centre at the University of Auckland, New Zealand. In addition, she is the director of Auckland Cytometry, the flow cytometry Shared Resource Laboratory for the Faculty of Science. Anna also facilitated a collaboration with Auckland Genomics to establish a pipeline for single cell transcriptomics (scRNAseq), the first of its kind in New Zealand.
Anna is experienced in multicolour panel development, especially the characterisation of complex cellular populations in digested human tissues. Anna’s current research interest lies in dissecting the heterogeneity of mesenchymal cells in human adipose tissue using both flow cytometric and proteogenomic techniques (CITEseq/scRNAseq). In addition, Anna is a consultant for an on-going international collaboration with the role of developing and analysing high dimensional spectral cytometry panels (26 colours) to monitor immune responses for clinical trials using the Cytek Aurora.
Anna is an active member of the international flow cytometry community, is passionate about teaching flow cytometric best practices and has presented and facilitated a number of workshops, including at the international CYTO conferences. She has also sat on a number of conference organising and national grant reviewing committees and is chairing the annual ACS meeting in 2020 in Queenstown. As well as ACS, Anna is also a member of the Australian Society for Immunology, the Australasian Society for Stem Cell Research, the International Society for Cell and Gene Therapy, the International Society for Advancement of Cytometry and the International Society for Stem Cell Research.
Dr Neil Came
Dr Neil Came is a Haematopathologist, working in close collaboration with clinical and pathology colleagues to provide a high standard of care in the diagnosis and monitoring of a wide range of haematological cancers, as well as transfusion and coagulation support of all patients at Peter Mac. Neil’s research interest is disease response assessment of plasma cell myeloma. He is an active member of Australian, American and European haematology and flow cytometry societies; is currently working with ICCS and ESCCA toward an international consensus method for minimal residual disease assessment of multiple myeloma by flow cytometry; and is on the editorial board of the journal Cytometry Part B, Clinical Cytometry.
Suat Dervish is an ISAC SRL Emerging Leader. Having obtained his B.MedSci (Hons) focusing on T cell immunology from the University of Sydney and subsequently working as a Cytometry Development Specialist at the Advanced Cytometry Facility, he currently manages Westmead Cytometry driving quality data generation and technological developments to facilitate translational medical research. He has presented workshops including “Quality Cell Sorting” at Cyto, has developed software used internationally to improve cell sorts and has developed means for >8-way simultaneous biological cell sorting. His innovative spirit has been recognised, being awarded an AMP Tomorrow Maker Grant, an Entrepreneurial Sydney University Union Kick Start Grant and with completion of the GradCert in Innovation & Enterprise. He currently teaches the Cytometry component to undergraduates as part of the AMED course at the University of Sydney and has hosted the “Build Your Own Cytometer” workshop at the Australian Cytometry Society Conferences.
Dr Shaun Fleming
Dr Shaun Fleming is a clinical and laboratory haematologist at the Alfred Hospital, Northern Health and Monash Health. He has an active role in the management and research into acute leukaemias, in particular acute lymphoblastic leukaemia. He is the chief investigator on the Australasian Leukaemia & Lymphoma Group (ALLG) ALL8 study exploring the use of the novel immunotherapy blinatumomab in up-front management of adult ALL. Shaun works as a diagnostic haematologist at the Alfred with a focus on flow cytometry where he has guided the development of a single-tube 10-colour ALL panel now utilised in routine testing at the Alfred.
Dr Alvin Lo
Alvin Lo is a WEHI Biologics fellow working in Wai-Hong Tham’s lab. He obtained his PhD in molecular microbiology from The University of Melbourne. He spent 5 years in Belgium at the Structural Biology Lab of the Free University of Brussels where he worked on small compound screening and the development of nanobodies against pathogenic bacteria. He then moved back to Australia and joined the School of Chemistry and Molecular Biosciences, University of Queensland and worked on the structural studies of virulence proteins involved in bacterial pathogenesis. Alvin is now at WEHI working on single B cell cloning for recombinant antibody production and the generation of alpaca nanobodies.
Associate Professor Alex Swarbrick
Alex is an Associate Professor of Medicine at UNSW Sydney, Laboratory Head in the Garvan Institute of Medical Research, NHMRC Senior Research Fellow and co-head of the Breast Translational Oncology Program in the Kinghorn Cancer Center, Sydney. Alex completed his PhD at UNSW, followed by a postdoctoral fellowship with Nobel Laureate J. Michael Bishop at UCSF. Alex uses cell and molecular biology, animal models of disease and single cell genomics to find new treatment strategies for breast and prostate cancer.
Dr Charis Teh
Charis is a NHMRC Early Career Fellow at the Walter and Eliza Hall Institute of Medical Research. Charis received a BSc from ANU (2007), MPH from University of Sydney (2014) and PhD from the ANU (2012). She has developed technical expertise and knowledge in immunology, cancer, cell death, and mass cytometry technology at world-renowned laboratories – Prof Garry Nolan (Stanford University), Associate Prof Daniel Gray (WEHI) and Prof Christopher Goodnow (ANU). She is currently channelling her efforts to understand the survival and death signals that control immune cells and how this can be harnessed for treatment of autoimmunity and blood cancers.
Associate Professor David Westerman
David Westerman is a University of Melbourne graduate with dual fellowships and has held his current position as Head of Haematopathology at Peter MacCallum Cancer Centre, since 2000. He is Deputy Director of the Dept of Pathology, Chair of the Transfusion Medicine Committee and holds honorary appointments with the University of Melbourne at St Vincent’s Hospital Clinical School, and the Sir Peter MacCallum Dept of Oncology. He is a member of the RCPA immunophenotyping committee. He has broad clinical and laboratory academic interests including teaching, flow cytometry, molecular haematology and biomarkers which are reflected by over 100 peer reviewed publications.